In the Original Investigation titled “Long-term Outcomes of Transcatheter Arterial Chemoembolization Combined With Radiofrequency Ablation as an Initial Treatment for Early-Stage Hepatocellular Carcinoma,”1 published September 27, 2021, there were errors in the number of patients included at several stages of the flow diagram in Figure 1. This article has been corrected.1
Reference
- 1.Zhang YJ, Chen MS, Chen Y, Lau WY, Peng Z. Long-term outcomes of transcatheter arterial chemoembolization combined with radiofrequency ablation as an initial treatment for early-stage hepatocellular carcinoma. JAMA Netw Open. 2021;4(9):e2126992. doi: 10.1001/jamanetworkopen.2021.26992 [DOI] [PMC free article] [PubMed] [Google Scholar]